Scott Bazemore

Texas

Clinical Oncology Research Excellence, LLC (CORE) collaborates with medical oncology practices on the scientific and administrative fronts to create or continue development of their clinical research needs, including all aspects of site assessment, pipeline development and business management. Our purpose is to partner with physicians to provide the best options for their patients while creating a financially sound research program. Scott Bazemore has over 25 years of experience in drug development research. His past experience includes designing clinical trial portfolios in oncology / hematology disease states for academic sites as well as multiple nationally recognized private practice networks. He has been successful in creating effective processes that surround physician education as well as promoting access to Pharma pipelines that enable physicians to proactively seek trials that resonate with their patients. Scott has developed a rapport with key opinion leaders in the field of oncology and key decision makers within the Pharma / Biotech community. He has led both national oncology meetings such as ASCO, ASH, and SABCS and targeted development meetings with pharmaceutical and life science companies.